Pharmacy Benefit Managers (PBMs) are increasingly utilizing gag clauses in pharmacy contracts as a means of prohibiting pharmacies from telling customers that paying for drugs out of pocket would cost them less than if they used their insurance and paid their copays. Critics argue that this practice results in artificially inflated prescription drugs costs.

In this episode, Richard Church and Ryan Severson discuss recent litigation stemming from these gag clauses, as well as various state and federal efforts to prohibit PBMs from using gag clauses in their pharmacy contracts, including a proposal in President Trump’s recently released drug pricing plan.

Click here to listen to the podcast.